ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 983,03
0,57%
Dow Jones
38 801,57
0,23%
DAX
18 575,94
0,86%
Brent Oil
78,385
1,65%
Bitcoin
71 431,13
1,14%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cancer Genetics Inc (CGIX)

  7. Cancer Genetics Inc (CGIX) Actualités

CGIX

Cancer Genetics (CGIX)

Cancer Genetics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CGIX
DateHeureSourceTitreSymboleSociété
15/05/202314h01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CGIXCancer Genetics Inc
10/05/202314h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CGIXCancer Genetics Inc
04/05/202322h33Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:CGIXCancer Genetics Inc
28/03/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CGIXCancer Genetics Inc
24/03/202314h05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CGIXCancer Genetics Inc
24/03/202313h35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CGIXCancer Genetics Inc
19/01/202322h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CGIXCancer Genetics Inc
14/11/202222h46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CGIXCancer Genetics Inc
15/08/202214h01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:CGIXCancer Genetics Inc
14/06/202222h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CGIXCancer Genetics Inc
03/06/202222h06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CGIXCancer Genetics Inc
12/05/202215h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:CGIXCancer Genetics Inc
29/04/202223h46Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:CGIXCancer Genetics Inc
11/04/202212h01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CGIXCancer Genetics Inc
30/03/202213h39Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CGIXCancer Genetics Inc
14/02/202219h04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CGIXCancer Genetics Inc
11/02/202213h37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CGIXCancer Genetics Inc
29/12/202122h31Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CGIXCancer Genetics Inc
18/05/202112h02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CGIXCancer Genetics Inc
02/04/202101h02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CGIXCancer Genetics Inc
31/03/202112h30GlobeNewswire Inc.Cancer Genetics and StemoniX Announce Merger ClosingNASDAQ:CGIXCancer Genetics Inc
25/03/202114h16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CGIXCancer Genetics Inc
25/03/202114h15GlobeNewswire Inc.Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniXNASDAQ:CGIXCancer Genetics Inc
18/03/202113h30GlobeNewswire Inc.Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business DevelopmentNASDAQ:CGIXCancer Genetics Inc
12/03/202115h30GlobeNewswire Inc.Cancer Genetics to Present at the Annual 33rd ROTH ConferenceNASDAQ:CGIXCancer Genetics Inc
04/03/202122h15GlobeNewswire Inc.Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences ConferenceNASDAQ:CGIXCancer Genetics Inc
26/02/202122h51Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:CGIXCancer Genetics Inc
16/02/202122h45GlobeNewswire Inc.Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq RulesNASDAQ:CGIXCancer Genetics Inc
11/02/202105h00GlobeNewswire Inc.Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq RulesNASDAQ:CGIXCancer Genetics Inc
08/02/202122h56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CGIXCancer Genetics Inc
 Showing the most relevant articles for your search:NASDAQ:CGIX

Dernières Valeurs Consultées

ASX
D2O
Duxton Water
USOTC
GMBLZ
Esports Entertainment (PK)
COIN
JFITKNUST
JuFi Token
TG
WEK0
Alaunos Therapeutics
BIT
P1MDS2
NLBNPIT1MDS2 20240621 28...
ASX
MIN
Mineral Resources
NASDAQ
LRAD
LRAD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés